SA PRO
Free Account
Aligos Therapeutics, Inc.ALGSNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 60% recommend buying.

Consensus Rating
Buy
5 analysts·Limited coverage
60%
Rating Distribution
Strong Buy
00%
Buy
360%
Hold
240%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 152% higher.

Bear Case
$20.00
+152%
Consensus
$20.00
+152%
Bull Case
$20.00
+152%
Price Range5 analysts
Low
Consensus
High
$20.00
$20.00
Current Target
Current Price
$7.95
Upside to Target
$12.05

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 7, 2026UBS
UBS Starts Aligos Therapeutics Inc. (ALGS) at Buy
Target:$20.00
+128.3%from $8.76
Jan 6, 2023Piper Sandler
Piper Sandler Upgrades Aligos Therapeutics to Overweight, Raises Price Target to $3
Target:$3.00
+146.9%from $1.22
Jan 6, 2023Jefferies
Jefferies Upgrades Aligos Therapeutics to Buy, Raises Price Target to $3
Target:$3.00
+203.0%from $0.99

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance